This inventor holds 5 USPTO granted patents and 3 EPO patents. Top assignee: Caregen Co., Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Eung Ji Lee: Innovator in Peptide Research
Introduction
Eung Ji Lee is a prominent inventor based in Anyang-si, Gyeonggi-do, South Korea. He has made significant contributions to the field of peptide research, particularly in the context of combating viral infections. With a total of 5 patents to his name, Lee is recognized for his innovative approaches to medical science.
Latest Patents
Among his latest patents is the "TROLOX-PEPTIDE CONJUGATE AND USE THEREOF," which focuses on a peptide with neutralizing activity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This groundbreaking work highlights his commitment to addressing critical health challenges through scientific innovation.
Career Highlights
Eung Ji Lee is currently employed at Caregen Co., Ltd., a company known for its advancements in biotechnology and peptide-based products. His work at Caregen has positioned him as a key player in the development of therapeutic solutions that leverage the power of peptides.
Collaborations
Lee collaborates with talented colleagues, including Yong Ji Chung and Eun Mi Kim, who contribute to his research endeavors. Their combined expertise fosters a dynamic environment for innovation and discovery.
Conclusion
Eung Ji Lee's contributions to peptide research and his innovative patents underscore his role as a leading inventor in the field. His work not only advances scientific knowledge but also holds the potential to impact public health positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile